EBAMed

Geneva, Switzerland · Founded 2018 · Privately Held (backing)

Developer of the next-generation radiation therapy technology designed to treat cardiac arrhythmias from outside the heart. EBAMed is based in Geneva, Switzerland and was founded in 2018. Its last reported valuation was $106 million in Jun 2025. It has raised $51.1 million.

Last reported valuation

$105.6M

Oct 2026

Priced at

—

Total raised

$51.1M

Last round

—

How much has EBAMed raised?

$51.1Macross 0 recorded rounds

Free account

More of EBAMed with a free account

·The complete investor list: 13 names
·Watch EBAMed: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

EBAMed investors

13 investors are on record for EBAMed, including MassChallenge, European Innovation Council, Venture Kick and CDP Venture Capital (Rome).

For fundraisers

Raising for a company like EBAMed?

13 investors have backed EBAMed.

See all 13 investors →

Frequently asked about EBAMed

How much has EBAMed raised?: EBAMed has raised $51.1M in total across 0 recorded funding rounds.